https://www.selleckchem.com/pr....oducts/gsk1838705a.h
Background To evaluate the long-term efficacy and safety of topical 1% atropine for retarding moderate myopia. Methods A randomized, controlled study evaluating atropine and placebo in 660 Chinese children. Patients received drops q1month for 24 months, then q2month for 12 months, followed by no drops for 12 months. Spherical equivalent, axial length, intraocular pressure and atropine-related side effects were examined at 6, 12, 24, 36 and 48 months for all children. Results Spherical equivalent, myopic progression, axial length aug
Like
Comment
Share
